This is the authors' abstract. We don't add key points for this paper.
The panel formulated and provided the rationale for recommendations in favor of or against treatment interventions for idiopathic pulmonary fibrosis.
No takes yet. Share an insight, caveat, or question.
Raghu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: